[Alpha-blockers and treatment of coronary artery vasospasm].
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000471:Alkalosis / Q000150:complications; D003329:Coronary Vasospasm / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009530:Nicergoline / Q000008:administration & dosage / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000008:administration & dosage / Q000627:therapeutic use; D010646:Phentolamine / Q000008:administration & dosage / Q000627:therapeutic use; D014666:Vasomotor System / Q000503:physiopathology
D000317:Adrenergic alpha-Antagonists; D010643:Phenoxybenzamine; D009530:Nicergoline; D010646:Phentolamine
Alpha-bloquants et traitement du spasme artériel coronaire.